FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1960873 · Received January 12, 2011

Report

Report Number
2953200-2011-00073
Event Type
Injury
Date Received
January 12, 2011
Date of Event
October 6, 2010
Report Date
December 13, 2010
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4): EVAL RESULTS: (STROKE).

Description of Event or Problem · 1

DURING THE INDEX PROCEDURE THE PT HAD 3 ENDEAVOR SPRINT RX DRUG-ELUTING STENTS IMPLANTED IN THE PROXIMAL LCX (REF:MFR2953200-2011-00074, 2953200-2011-00075). IT WAS REPORTED THAT AT THE 30 DAY F/U THE PT HAD STABLE ANGINA. APPROX 2 MONTHS POST THE INDEX PROCEDURE THE PT HAD A PTCA TO TREAT A REVASCULARIZATION OF THE PROXIMAL AND MID RCA. THREE MORE ENDEAVOR SPRINT RX DRUG-ELUTING STENTS WERE IMPLANTED (REF: MFR2953200-2011-00076, 2953200-2011-00077, 2953200-2011-00078). AT THE 6 MONTH F/U THE PT WAS REPORTEDLY FREE OF SYMPTOMS. NO CLINICAL F/U WAS COMPLETED AT THE 1.5 YEAR F/U DUE TO THE PT'S HIGH WORK LOAD. THE PT WAS REPORTEDLY FREE OF SYMPTOMS AT THE 2 YEAR AND 2.5 YEAR F/U. IT WAS HOWEVER REPORTED THAT THE PT SUFFERED A STROKE APPROX 30 MONTHS POST THE INDEX PROCEDURE AND ANOTHER STROKE 3 DAYS POST THE FIRST STROKE. IT WAS CONFIRMED THAT THE STROKES WERE NOT RELATED TO THE STUDY STENT OR TO THE STUDY PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0000566138

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization EVENT.| THE PT HAS BEEN TAKING ASA 24 HOURS BEFORE THE| THE PT HAS BEEN TAKING CLOPIDOGREL 24 HOURS BEFORE| THE EVENT.